$VREX Market Cap: $669.5 Million
Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue
$621.0M
TTM
Gross Margin
32.17%
TTM
Net Earnings
-$47.20M
TTM
Current Assets
$656.9M
Q1 2025
Current Liabilities
$150.5M
Q1 2025
Current Ratio
436.48%
Q1 2025
Total Assets
$1.332B
Q1 2025
Total Liabilities
$778.0M
Q1 2025
Book Value
$554.2M
Q1 2025
Cash
$176.0M
Q1 2025
P/E
-14.18
Nov 29, 2024 EST
Free Cash Flow
$20.50M
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue $811.0M $893.4M $859.4M $818.1M $738.3M $780.6M $773.4M $698.1M $620.1M $632.3M $685.2M $669.8M
YoY Change -9.22% 3.96% 5.05% 10.81% -5.42% 0.93% 10.79% 12.58% -1.93% -7.72% 2.3%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue $811.0M $893.4M $859.4M $818.1M $738.3M $780.6M $773.4M $698.1M $620.1M $632.3M $685.2M $669.8M
Cost Of Revenue $554.1M $603.1M $575.9M $546.6M $548.1M $523.9M $519.5M $444.6M $371.7M $381.7M $406.6M $401.7M
Gross Profit $256.9M $290.3M $283.5M $271.5M $190.2M $256.7M $253.9M $253.5M $248.4M $250.6M $278.6M $268.1M
Gross Profit Margin 31.68% 32.49% 32.99% 33.19% 25.76% 32.88% 32.83% 36.31% 40.06% 39.63% 40.66% 40.03%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Selling, General & Admin $137.8M $128.4M $118.3M $125.5M $142.2M $128.1M $123.4M $102.5M $85.80M $72.70M $62.60M $61.70M
YoY Change 7.32% 8.54% -5.74% -11.74% 11.01% 3.81% 20.39% 19.46% 18.02% 16.13% 1.46%
% of Gross Profit 53.64% 44.23% 41.73% 46.22% 74.76% 49.9% 48.6% 40.43% 34.54% 29.01% 22.47% 23.01%
Research & Development $87.00M $84.80M $77.00M $71.90M $78.90M $78.10M $83.00M $67.30M $53.50M $50.40M $40.00M $35.90M
YoY Change 2.59% 10.13% 7.09% -8.87% 1.02% -5.9% 23.33% 25.79% 6.15% 26.0% 11.42%
% of Gross Profit 33.87% 29.21% 27.16% 26.48% 41.48% 30.42% 32.69% 26.55% 21.54% 20.11% 14.36% 13.39%
Depreciation & Amortization $21.20M $19.50M $19.00M $20.50M $22.30M $23.50M $26.00M $16.90M $9.800M $9.600M $10.10M $10.10M
YoY Change 8.72% 2.63% -7.32% -8.07% -5.11% -9.62% 53.85% 72.45% 2.08% -4.95% 0.0%
% of Gross Profit 8.25% 6.72% 6.7% 7.55% 11.72% 9.15% 10.24% 6.67% 3.95% 3.83% 3.63% 3.77%
Operating Expenses $224.8M $213.2M $195.3M $197.4M $223.9M $211.0M $209.4M $169.8M $139.3M $123.1M $102.6M $97.60M
YoY Change 5.44% 9.17% -1.06% -11.84% 6.11% 0.76% 23.32% 21.9% 13.16% 19.98% 5.12%
Operating Profit $32.10M $77.10M $88.20M $74.10M -$33.70M $45.70M $44.50M $83.70M $109.1M $127.5M $176.0M $170.5M
YoY Change -58.37% -12.59% 19.03% -319.88% -173.74% 2.7% -46.83% -23.28% -14.43% -27.56% 3.23%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Interest Expense -$26.20M $29.30M $39.80M $42.10M $31.40M $21.10M $21.70M $12.30M $1.900M $1.200M -$1.800M $2.500M
YoY Change -189.42% -26.38% -5.46% 34.08% 48.82% -2.76% 76.42% 547.37% 58.33% -166.67% -172.0%
% of Operating Profit -81.62% 38.0% 45.12% 56.82% 46.17% 48.76% 14.7% 1.74% 0.94% -1.02% 1.47%
Other Income/Expense, Net -$27.10M -$45.80M -$43.70M -$45.50M -$38.90M -$24.20M -$18.80M -$8.900M -$4.100M $100.0K
YoY Change -40.83% 4.81% -3.96% 16.97% 60.74% 28.72% 111.24% 117.07% -4200.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Pretax Income $5.000M $31.30M $44.50M $28.60M -$72.60M $21.50M $25.70M $74.80M $105.0M $127.6M $174.2M $171.3M
YoY Change -84.03% -29.66% 55.59% -139.39% -437.67% -16.34% -65.64% -28.76% -17.71% -26.75% 1.69%
Income Tax $52.20M -$17.40M $13.70M $10.70M -$15.20M $5.700M -$2.600M $22.80M $36.00M $46.80M $64.10M $61.70M
% Of Pretax Income 1044.0% -55.59% 30.79% 37.41% 26.51% -10.12% 30.48% 34.29% 36.68% 36.8% 36.02%
Net Earnings -$47.70M $48.20M $30.30M $17.40M -$57.90M $15.50M $27.50M $51.60M $68.50M $80.00M $110.1M $109.6M
YoY Change -198.96% 59.08% 74.14% -130.05% -473.55% -43.64% -46.71% -24.67% -14.38% -27.34% 0.46%
Net Earnings / Revenue -5.88% 5.4% 3.53% 2.13% -7.84% 1.99% 3.56% 7.39% 11.05% 12.65% 16.07% 16.36%
Basic Earnings Per Share -$1.17 $1.20 $0.76 $0.44 -$1.49 $0.41 $0.73 $1.37 $1.83 $2.14
Diluted Earnings Per Share -$1.17 $1.08 $0.73 $0.43 -$1.49 $0.40 $0.72 $1.36 $1.82 $2.12 $2.944M $2.930M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Cash & Short-Term Investments $200.5M $192.6M $89.40M $144.6M $100.6M $29.90M $51.90M $83.30M $36.50M $20.60M $500.0K
YoY Change 4.1% 115.44% -38.17% 43.74% 236.45% -42.39% -37.7% 128.22% 77.18% 4020.0%
Cash & Equivalents $168.7M $152.6M $89.40M $144.6M $100.6M $29.90M $51.90M $83.30M $36.50M $20.60M $500.0K
Short-Term Investments $31.80M $40.00M $14.50M
Other Short-Term Assets $26.90M $24.60M $44.00M $29.50M $25.70M $19.30M $17.10M $13.90M $3.800M $2.800M $1.800M
YoY Change 9.35% -44.09% 49.15% 14.79% 33.16% 12.87% 23.02% 265.79% 35.71% 55.56%
Inventory $264.8M $277.5M $303.2M $224.8M $271.9M $248.2M $235.1M $234.5M $197.4M $174.9M $139.6M
Prepaid Expenses
Receivables $157.7M $163.6M $173.3M $155.3M $123.8M $141.0M $154.0M $163.6M $122.2M $117.8M $128.7M
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $649.9M $658.3M $609.9M $554.2M $522.0M $438.4M $458.1M $495.3M $359.9M $316.1M $270.6M
YoY Change -1.28% 7.94% 10.05% 6.17% 19.07% -4.3% -7.51% 37.62% 13.86% 16.81%
Property, Plant & Equipment $181.7M $172.6M $164.5M $164.5M $172.9M $142.3M $144.9M $148.3M $108.9M $96.20M $63.00M
YoY Change 5.27% 4.92% 0.0% -4.86% 21.5% -1.79% -2.29% 36.18% 13.2% 52.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $26.80M $29.00M $46.40M $49.30M $51.30M $53.60M $51.00M $52.30M $49.30M $58.70M $49.70M
YoY Change -7.59% -37.5% -5.88% -3.9% -4.29% 5.1% -2.49% 6.09% -16.01% 18.11%
Other Assets $51.50M $78.80M $45.50M $36.60M $32.70M $27.50M $16.50M $11.00M $8.900M $13.90M $9.100M
YoY Change -34.64% 73.19% 24.32% 11.93% 18.91% 66.67% 50.0% 23.6% -35.97% 52.75%
Total Long-Term Assets $567.1M $591.3M $574.5M $593.3M $617.5M $600.5M $529.8M $544.8M $262.5M $267.5M $162.5M
YoY Change -4.09% 2.92% -3.17% -3.92% 2.83% 13.34% -2.75% 107.54% -1.87% 64.62%
Total Assets $1.217B $1.250B $1.184B $1.148B $1.140B $1.039B $987.9M $1.040B $622.4M $583.6M $433.1M
YoY Change
Accounts Payable $59.10M $64.70M $78.20M $58.80M $72.90M $58.20M $66.30M $58.90M $41.90M $49.70M $41.80M
YoY Change -8.66% -17.26% 32.99% -19.34% 25.26% -12.22% 12.56% 40.57% -15.69% 18.9%
Accrued Expenses $64.00M $65.90M $85.40M $95.70M $76.40M $65.00M $47.50M $49.20M $23.70M $18.40M $23.10M
YoY Change -2.88% -22.83% -10.76% 25.26% 17.54% 36.84% -3.46% 107.59% 28.8% -20.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $46.70M $1.600M $2.100M $3.000M $2.700M $30.70M $25.00M $20.00M
YoY Change 2818.75% -23.81% -30.0% 11.11% -91.21% 22.8% 25.0%
Total Short-Term Liabilities $195.9M $162.8M $173.1M $166.6M $160.6M $175.1M $152.0M $151.8M $77.80M $78.60M $68.80M
YoY Change 20.33% -5.95% 3.9% 3.74% -8.28% 15.2% 0.13% 95.12% -1.02% 14.24%
Long-Term Debt $403.0M $441.3M $412.3M $432.0M $453.2M $364.4M $364.8M $463.9M $0.00 $0.00 $0.00
YoY Change -8.68% 7.03% -4.56% -4.68% 24.37% -0.11% -21.36%
Other Long-Term Liabilities $67.50M $64.50M $51.80M $50.20M $57.60M $32.50M $8.500M $4.700M $5.300M $5.600M $5.000M
YoY Change 4.65% 24.52% 3.19% -12.85% 77.23% 282.35% 80.85% -11.32% -5.36% 12.0%
Total Long-Term Liabilities $470.5M $505.8M $464.1M $482.2M $510.8M $396.9M $373.3M $468.6M $5.300M $5.600M $5.000M
YoY Change -6.98% 8.99% -3.75% -5.6% 28.7% 6.32% -20.34% 8741.51% -5.36% 12.0%
Total Liabilities $681.9M $681.9M $651.0M $664.2M $687.8M $594.0M $561.7M $661.1M $96.40M $99.00M $73.80M
YoY Change 0.0% 4.75% -1.99% -3.43% 15.79% 5.75% -15.04% 585.79% -2.63% 34.15%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Basic Shares Outstanding 40.80M shares 40.30M shares 39.80M shares 39.30M shares 38.80M shares 38.20M shares 37.90M shares 37.60M shares 37.40M shares 37.40M shares
Diluted Shares Outstanding 40.80M shares 50.30M shares 41.60M shares 40.30M shares 38.80M shares 38.60M shares 38.40M shares 38.00M shares 37.70M shares 37.70M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $669.52 Million

About Varex Imaging Corp

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. The company is headquartered in Salt Lake City, Utah. The company went IPO on 2017-01-20. The firm operates through two segments: Medical and Industrial. The Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, digital detectors, ionization chambers and buckys, high voltage connectors, image-processing software and workstations, three-dimensional (3D) reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. These components are used in a range of medical imaging applications. The Industrial segment designs, develops, manufactures, sells and services X-ray imaging products for use in a number of markets, including security applications for cargo screening at ports and borders and baggage screening at airports, and nondestructive testing, irradiation and inspection applications used in various other markets.

Industry: Electronic Components, NEC Peers: ABBOTT LABORATORIES Alphatec Holdings, Inc. CUTERA INC ANGIODYNAMICS INC Butterfly Network, Inc. Cryoport, Inc. HESKA CORP LEMAITRE VASCULAR INC